
ADVICENNE (PROM.) EO-,20
Share · FR0013296746 · A2H8SU (XPAR)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ADVICENNE (PROM.) EO-,20
No Price
Closing Price XPAR 29.04.2026:
1,27 EUR
29.04.2026 07:29
Current Prices from ADVICENNE (PROM.) EO-,20
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
Paris |
ALDVI.PA
|
EUR
|
29.04.2026 07:29
|
1,27 EUR
| 0,002 EUR
+0,16 %
|
Quotrix |
AANPEO46.DUSD
|
EUR
|
29.04.2026 05:27
|
1,27 EUR
| 0,01 EUR
+0,95 %
|
Düsseldorf |
AANPEO46.DUSB
|
EUR
|
28.04.2026 06:13
|
1,21 EUR
| -0,05 EUR
-3,97 %
|
Company Profile for ADVICENNE (PROM.) EO-,20 Share
Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.
Company Data
Name ADVICENNE (PROM.) EO-,20
Company Advicenne S.A.
Website
https://www.advicenne.com
Primary Exchange
Paris
WKN A2H8SU
ISIN FR0013296746
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Andr Ulmann
Market Capitalization 18 Mio
Country France
Currency EUR
Employees 0,0 T
Address 2 Rue Briconnet, 75002 Nimes
IPO Date 2017-12-06
Stock Splits
| Date | Split |
|---|---|
| 13.09.2023 | 509:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | AANPEO46.DUSB |
| Frankfurt | 3MM.F |
| Paris | ADVIC.PA |
| Paris | ALDVI.PA |
| Quotrix | AANPEO46.DUSD |
More Shares
Investors who hold ADVICENNE (PROM.) EO-,20 also have the following shares in their portfolio:
